Top Vaccines companies in France by EBIT Margin

This ranking features the top 17 Vaccines companies in France ranked by EBIT Margin, averaging a EBIT Margin of -299.74%, for February 06, 2025.
#
Name
EBIT Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
17.86%
Dec. 31, 2023 USD 107.78 1.15%

France

2
14.70%
Dec. 31, 2023 USD 75.53 2.94%

France

3
10.30%
Dec. 31, 2023 USD 3.53 -0.92%

France

4
7.88%
Dec. 31, 2023 USD 26.53 -0.92%

France

5
-24.41%
Dec. 31, 2023 USD 2.01 -0.78%

France

6
-48.99%
Dec. 31, 2023 USD 3.21 17.34%

France

7
-54.30%
Dec. 31, 2023 USD 2.58 -11.21%

France

8
-105.12%
Dec. 31, 2023 USD 3.47 -1.52%

France

9
-151.00%
Dec. 31, 2023 USD 1.39 1.77%

France

10
-170.22%
March 31, 2024 USD 16.83 1.50%

France

11
-240.83%
Dec. 31, 2023 USD 0.65 1.19%

France

12
-527.02%
Dec. 31, 2023 USD 4.22 -0.94%

France

13
-598.32%
Dec. 31, 2023 USD 2.43 0.68%

France

14
-923.35%
Dec. 31, 2023 USD 5.64 -2.27%

France

15
-944.14%
Dec. 31, 2023 USD 6.63 -0.22%

France

16
-1,058.87%
Dec. 31, 2023 USD 1.64 4.90%

France

17
-2,897.94%
Dec. 31, 2023 USD 5.91 -2.66%

France

Frequently Asked Questions
  • Which Vaccines company in France has the highest EBIT Margin ?

    The Vaccines company in France with the highest EBIT Margin is Sanofi (Paris Stock Exchange: SAN.PA) at 17.86%.

  • Which Vaccines company in France has the lowest EBIT Margin ?

    The Vaccines company in France with the lowest EBIT Margin is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at -2,897.94%.

SV Wall Street